LV11738B - Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors - Google Patents

Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors Download PDF

Info

Publication number
LV11738B
LV11738B LVP-96-428A LV960428A LV11738B LV 11738 B LV11738 B LV 11738B LV 960428 A LV960428 A LV 960428A LV 11738 B LV11738 B LV 11738B
Authority
LV
Latvia
Prior art keywords
tropane
dichlorophenyl
aldoxime
compound
alkyl
Prior art date
Application number
LVP-96-428A
Other languages
English (en)
Latvian (lv)
Other versions
LV11738A (lv
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of LV11738A publication Critical patent/LV11738A/xx
Publication of LV11738B publication Critical patent/LV11738B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
LVP-96-428A 1994-04-19 1996-11-11 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors LV11738B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
LV11738A LV11738A (lv) 1997-04-20
LV11738B true LV11738B (en) 1997-12-20

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-428A LV11738B (en) 1994-04-19 1996-11-11 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors

Country Status (25)

Country Link
US (1) US5736556A (uk)
EP (1) EP0756596B1 (uk)
JP (1) JP2899418B2 (uk)
KR (1) KR100210417B1 (uk)
CN (1) CN1043763C (uk)
AT (1) ATE222587T1 (uk)
AU (1) AU690257B2 (uk)
BG (1) BG63259B1 (uk)
BR (1) BR9507489A (uk)
CA (1) CA2187309C (uk)
CZ (1) CZ284379B6 (uk)
DE (1) DE69527839T2 (uk)
DK (1) DK0756596T3 (uk)
EE (1) EE03877B1 (uk)
FI (1) FI965074A0 (uk)
GE (1) GEP19991749B (uk)
HU (1) HU215830B (uk)
LV (1) LV11738B (uk)
NO (1) NO964180L (uk)
NZ (1) NZ284075A (uk)
PL (1) PL183025B1 (uk)
RU (1) RU2134264C1 (uk)
SK (1) SK280875B6 (uk)
UA (1) UA49801C2 (uk)
WO (1) WO1995028401A1 (uk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9802433A3 (en) * 1995-10-13 2000-03-28 Neurosearch As 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US5998405A (en) * 1995-11-02 1999-12-07 Neurosearch A/S Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
RU2167876C2 (ru) 1996-02-22 2001-05-27 Ньюросерч А/С 2,3-трансдизамещенное тропановое производное, способ его получения, фармацевтическая композиция
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
EP1261340B1 (en) 1999-07-13 2009-05-13 Alpha Research Group, LLC Compositions and methods for the treatment of parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
EP1284974B1 (en) * 2000-05-26 2004-03-03 Pfizer Limited Triazolyl tropane derivatives as ccr5 modulators
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
EP1397358A1 (en) * 2001-05-23 2004-03-17 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
JP2005529156A (ja) * 2002-03-28 2005-09-29 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ トロパン化合物
ES2295924T3 (es) 2003-10-03 2008-04-16 Pfizer, Inc. Derivados de tropano imidazopirina sustituidos con actividad antagonista de los receptores ccr5 para el tratamiento de vih y de la inflamacion.
MXPA06003762A (es) * 2003-10-16 2006-06-14 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de recaptacion de neurotransmisor monoamina y un inhibidor de acetilcolinesterasa.
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
EP1727547A1 (en) * 2004-01-22 2006-12-06 Neurosearch A/S Compounds for the sustained reduction of body weight
WO2006075976A1 (fr) * 2005-01-14 2006-07-20 Private Enterprise 'slavyanskaya Klinika' Utilisation d'un anesthesique local pour corriger un comportement alimentaire humain, et procede d'utilisation associe
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
CZ284379B6 (cs) 1998-11-11
CZ298296A3 (en) 1997-06-11
BG100883A (en) 1998-03-31
JP2899418B2 (ja) 1999-06-02
LV11738A (lv) 1997-04-20
DE69527839T2 (de) 2003-01-02
CA2187309A1 (en) 1995-10-26
PL316876A1 (en) 1997-02-17
BR9507489A (pt) 1997-08-12
SK128896A3 (en) 1997-04-09
DK0756596T3 (da) 2002-12-23
CN1043763C (zh) 1999-06-23
PL183025B1 (pl) 2002-05-31
HU9602707D0 (en) 1996-11-28
FI965074A (fi) 1996-12-17
DE69527839D1 (en) 2002-09-26
US5736556A (en) 1998-04-07
GEP19991749B (en) 1999-09-10
WO1995028401A1 (en) 1995-10-26
EP0756596A1 (en) 1997-02-05
NO964180L (no) 1996-12-16
NZ284075A (en) 1998-01-26
UA49801C2 (uk) 2002-10-15
AU690257B2 (en) 1998-04-23
KR100210417B1 (ko) 1999-07-15
MX9604966A (es) 1998-05-31
BG63259B1 (bg) 2001-07-31
JPH09505607A (ja) 1997-06-03
CA2187309C (en) 2000-11-21
FI965074A0 (fi) 1996-12-17
RU2134264C1 (ru) 1999-08-10
EE03877B1 (et) 2002-10-15
HUT75865A (en) 1997-05-28
EE9600132A (et) 1997-04-15
HU215830B (hu) 2001-05-28
SK280875B6 (sk) 2000-08-14
EP0756596B1 (en) 2002-08-21
NO964180D0 (no) 1996-10-02
ATE222587T1 (de) 2002-09-15
AU2257595A (en) 1995-11-10
CN1148854A (zh) 1997-04-30

Similar Documents

Publication Publication Date Title
KR100310663B1 (ko) 트로판유도체,이의제조방법및이를함유하는약제학적조성물
LV11738B (en) Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors
AU720358B2 (en) Tropane-derivatives, their preparation and use
JP3462505B2 (ja) ８−アザビシクロ［３．２．１］オクト−２−エン誘導体、それらの製造及び使用
SK282944B6 (sk) Tavené tropánové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
CA2112084C (en) Antidepressant and antiparkinsonian compounds
US5554626A (en) Substituted heterocyclic compounds as dopamine-reuptake inhibitors
CA2112083C (en) Aryl substituted heterocyclic compounds
EP0604355B1 (en) Akyl Substituted heterocyclic compounds
MXPA96004966A (en) Tropan-2-aldoxine derivatives as inhibitors of neurotransmal restoration